Vanguard Group Inc Olema Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,871,613 shares of OLMA stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,871,613

Previous 2,685,009 6.95%

Holding current value

$12.1 Million

Previous $15.7 Million 31.02%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$3.76 - $6.39 $701,631 - $1.19 Million	186,604 Added 6.95%	2,871,613 $10.8 Million
Q4 2024 Feb 11, 2025	BUY	$5.61 - $12.72 $853,376 - $1.93 Million	152,117 Added 6.01%	2,685,009 $15.7 Million
Q3 2024 Nov 13, 2024	SELL	$10.41 - $16.46 $2.18 Million - $3.45 Million	-209,772 Reduced 7.65%	2,532,892 $30.2 Million
Q2 2024 Aug 13, 2024	BUY	$8.73 - $13.99 $2.92 Million - $4.69 Million	334,976 Added 13.91%	2,742,664 $29.7 Million
Q1 2024 May 10, 2024	SELL	$10.95 - $16.62 $3.27 Million - $4.96 Million	-298,207 Reduced 11.02%	2,407,688 $27.3 Million
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $10.5 Million - $17.1 Million	995,588 Added 58.21%	2,705,895 $38 Million
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $301,269 - $477,469	36,785 Added 2.2%	1,710,307 $21.1 Million
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $533,731 - $1.6 Million	165,755 Added 10.99%	1,673,522 $15.1 Million
Q1 2023 May 15, 2023	BUY	$2.55 - $4.97 $82,663 - $161,112	32,417 Added 2.2%	1,507,767 $5.23 Million
Q4 2022 Feb 10, 2023	BUY	$2.27 - $3.76 $1,636 - $2,710	721 Added 0.05%	1,475,350 $3.61 Million
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.88 $166,355 - $359,620	61,160 Added 4.33%	1,474,629 $4.07 Million
Q2 2022 Aug 12, 2022	BUY	$2.04 - $4.61 $53,598 - $121,123	26,274 Added 1.89%	1,413,469 $5.75 Million
Q1 2022 May 13, 2022	SELL	$3.89 - $9.43 $2.96 Million - $7.18 Million	-761,858 Reduced 35.45%	1,387,195 $5.91 Million
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $5.19 Million - $18.2 Million	-592,978 Reduced 21.63%	2,149,053 $20.1 Million
Q3 2021 Nov 12, 2021	BUY	$22.96 - $30.13 $6.42 Million - $8.43 Million	279,776 Added 11.36%	2,742,031 $75.6 Million
Q2 2021 Aug 13, 2021	BUY	$21.15 - $36.14 $52.1 Million - $89 Million	2,462,255 New	2,462,255 $68.9 Million

Others Institutions Holding OLMA

# of Institutions

135

Shares Held

64.3M

Call Options Held

6.3K

Put Options Held

15.2K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $171M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Olema Pharmaceuticals, Inc. Transaction History